Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia

Emerging evidence suggest a possible association between immune thrombocytopenia (ITP) and some formulations of COVID-19 vaccine. We conducted a retrospective case series of ITP following vaccination with Vaxzevria ChadOx1-S (AstraZeneca) and mRNA Comirnaty BNT162b2 COVID-19 (Pfizer-BioNTech) vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Sally F., Clothier, Hazel J., Morgan, Hannah, Buttery, Jim P., Phuong, Linny K., Monagle, Paul, Chunilal, Sanjeev, Wood, Erica M., Tran, Huyen, Szer, Jeff, Crawford, Nigel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556135/
https://www.ncbi.nlm.nih.gov/pubmed/34756770
http://dx.doi.org/10.1016/j.vaccine.2021.10.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556135/
https://www.ncbi.nlm.nih.gov/pubmed/34756770
http://dx.doi.org/10.1016/j.vaccine.2021.10.030

Ejemplares similares